| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 4862 | 2016 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The Lancet 386 (9995), 743-800, 2015 | 4428 | 2015 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 3978 | 2017 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … II Abubakar, T Tillmann, A Banerjee Lancet 385 (9963), 117-171, 2015 | 3598 | 2015 |
| The global burden of cancer 2013 C Fitzmaurice, D Dicker, A Pain, H Hamavid, M Moradi-Lakeh, ... JAMA oncology 1 (4), 505-527, 2015 | 1977 | 2015 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 1389 | 2015 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The Lancet 392 (10159), 1923-1994, 2018 | 703 | 2018 |
| Epstein‐Barr virus‐associated Hodgkin's disease: epidemiologic characteristics in international data SL Glaser, RJ Lin, SL Stewart, RF Ambinder, RF Jarrett, P Brousset, ... International journal of cancer 70 (4), 375-382, 1997 | 571 | 1997 |
| Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of … H Wang, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1084-1150, 2017 | 527 | 2017 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 463 | 2018 |
| Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 SS Lim, K Allen, ZA Bhutta, L Dandona, MH Forouzanfar, N Fullman, ... The Lancet 388 (10053), 1813-1850, 2016 | 443 | 2016 |
| Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα E Cabannes, G Khan, F Aillet, RF Jarrett, RT Hay Oncogene 18 (20), 3063-3070, 1999 | 416 | 1999 |
| A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma M Puyol, A Martín, P Dubus, F Mulero, P Pizcueta, G Khan, C Guerra, ... Cancer cell 18 (1), 63-73, 2010 | 374 | 2010 |
| Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA. G Khan, HO Kangro, PJ Coates, RB Heath Journal of clinical pathology 44 (5), 360-365, 1991 | 270 | 1991 |
| Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global … N Fullman, J Yearwood, SM Abay, C Abbafati, F Abd-Allah, J Abdela, ... The Lancet 391 (10136), 2236-2271, 2018 | 263 | 2018 |
| The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. LL Decker, P Shankar, G Khan, RB Freeman, BJ Dezube, J Lieberman, ... The Journal of experimental medicine 184 (1), 283-288, 1996 | 261 | 1996 |
| Is EBV persistence in vivo a model for B cell homeostasis? G Khan, EM Miyashita, B Yang, GJ Babcock, DA Thorley-Lawson Immunity 5 (2), 173-179, 1996 | 230 | 1996 |
| Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the … RM Barber, N Fullman, RJD Sorensen, T Bollyky, M McKee, E Nolte, ... The Lancet 390 (10091), 231-266, 2017 | 220 | 2017 |
| Detection of Epstein‐Barr virus (EBV) genomes in the serum of patients with EBV‐associated Hodgkin's disease A Gallagher, AA Armstrong, J MacKenzie, L Shield, G Khan, A Lake, ... International journal of cancer 84 (4), 442-448, 1999 | 172 | 1999 |
| Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 AH Mokdad, MH Forouzanfar, F Daoud, C El Bcheraoui, M Moradi-Lakeh, ... The Lancet Global Health 4 (10), e704-e713, 2016 | 156 | 2016 |
Philip CoatesMasaryk Memorial Cancer InstituteVerified email at mou.cz
